Holding(s) in Company

RNS Number : 8843M

Dechra Pharmaceuticals PLC

05 February 2009

 



For filings with the FSA include the annex For filings with issuer exclude the annex

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Dechra Pharmaceuticals plc

2. Reason for notification (yes/no)
An acquisition or disposal of voting rights	X
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):______________

3. Full name of person(s) subject to notification obligation:	Lloyds Banking Group plc
4. Full name of shareholder(s) (if different from 3):	See Section 9
5. Date of transaction (and date on which the threshold is crossed or reached if different):	4 February 2009
6. Date on which issuer notified:	5 February 2009
7. Threshold(s) that is/are crossed or reached:	Increase to above 5% Direct/Indirect

8: Notified Details
A: Voting rights attached to shares
Class/type of shares If possible use ISIN code	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of shares	Number of voting rights	Number of shares	Number of voting rights		Percentage of voting rights
				Direct	Indirect	Direct	Indirect
Ord 1p GB0009633180	N/A	N/A	855,578	855,578	2,421,243	1.31%	3.70%

B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/ conversion period/date	No. of voting rights that may be acquired (if the instrument exercised/converted)	Percentage of voting rights
N/A

Total (A+B)
Number of voting rights	Percentage of voting rights
3,276,821	5.00%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

2,941,041 shares (4.49%) are under the control of Insight Investment Management (Global) Limited, a wholly owned subsidiary of Insight Investment Management Limited, a wholly owned subsidiary of HBOS Insurance & Investment Group Limited, a wholly owned subsidiary of HBOS plc, a wholly owned subsidiary of Lloyds Banking Group plc (Indirect Interests).

Proxy Voting:
10. Name of proxy holder:	N/A
11. Number of voting rights proxy holder will cease to hold:	N/A
12. Date on which proxy holder will cease to hold voting rights:	N/A

13. Additional information:	Notification using the total voting rights figure of 65,488,594
14 Contact name:	Kenny Melville
15. Contact telephone number:	0131 243 8671

For notes on how to complete form TR-1 please see the FSA website. 

 

END

 

 

HOLZGGGZVKKGLZM